On May 4, Queen’s Park reporters Laura Stone and Jeff Gray answered reader questions about Ontario politics, including Doug ...
Sacituzumab govitecan (SG) + pembrolizumab (pembro) in first-line (1L) metastatic non-small cell lung cancer (mNSCLC) with PD-L1 ≥ 50%: Cohort A of EVOKE-02. Systemic efficacy (RECIST 1.1) and safety ...
Development and Validation of a Simulation Model–Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions Between January 18, 2012, and January 2, ...